China National Pharmaceutical Group Corporation announced its first-quarter performance, with a net profit attributable to the parent company of approximately 14.2 billion yuan, a year-on-year decrease of 10.7%

智通財經
2024.04.29 00:09

智通財經 APP 訊，國藥控股公佈 2024 年第一季度業績，營業總收入約 1472.66 億元，同比增長 1.2%;歸屬於母公司所有者的淨利潤約 14.2 億元，同比減少 10.7%;基本每股收益 0.46 元。

智通財經 APP 訊，國藥控股 (01099) 公佈 2024 年第一季度業績，營業總收入約 1472.66 億元，同比增長 1.2%;歸屬於母公司所有者的淨利潤約 14.2 億元，同比減少 10.7%;基本每股收益 0.46 元。

Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.